Shares of BioCorRx Inc. (OTCMKTS:BICX – Get Free Report) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $1.08 and traded as low as $0.82. BioCorRx shares last traded at $0.82, with a volume of 7,500 shares.
BioCorRx Stock Up 9.3 %
The stock has a market capitalization of $7.28 million, a price-to-earnings ratio of -1.82 and a beta of 0.59. The company has a 50 day simple moving average of $1.02 and a 200-day simple moving average of $1.08.
BioCorRx (OTCMKTS:BICX – Get Free Report) last released its quarterly earnings data on Monday, April 1st. The company reported ($0.11) earnings per share for the quarter. The firm had revenue of $0.02 million for the quarter.
About BioCorRx
BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.
Read More
- Five stocks we like better than BioCorRx
- Investing in Commodities: What Are They? How to Invest in Them
- High-Yield Texas Instruments Could Hit New Highs Soon
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- Dividend Payout Ratio Calculator
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for BioCorRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioCorRx and related companies with MarketBeat.com's FREE daily email newsletter.
